Financhill
Back

Galectin Therapeutics Vs. Phathom Pharmaceuticals Industry Stock Comparison

Sell
14

GALT
Galectin Therapeutics

Last Price:
$1.03
Seasonality Move:
33.46%
Sell
15

PHAT
Phathom Pharmaceuticals

Last Price:
$7.45
Seasonality Move:
-9.47%
Sell
14
Galectin Therapeutics (GALT) is a Sell

Is Galectin Therapeutics a Buy, Sell or Hold?

  • The current Galectin Therapeutics [GALT] share price is $1.03. The Score for GALT is 14, which is 72% below its historic median score of 50, and infers higher risk than normal.
  • GALT is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
15
Phathom Pharmaceuticals (PHAT) is a Sell

Is Phathom Pharmaceuticals a Buy, Sell or Hold?

  • The current Phathom Pharmaceuticals [PHAT] share price is $7.45. The Score for PHAT is 15, which is 70% below its historic median score of 50, and infers higher risk than normal.
  • PHAT is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

GALT Stock Price Chart

What is Galectin Therapeutics's stock price today?

  • The Galectin Therapeutics share price today is $1.03
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GALT is experiencing slight selling pressure.

PHAT Stock Price Chart

What is Phathom Pharmaceuticals's stock price today?

  • The Phathom Pharmaceuticals share price today is $7.45
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PHAT is experiencing selling pressure, which indicates risk of future bearish movement.

GALT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.25 Sell
Relative Strength Index (14 RSI): 20.76 Sell
Chaikin Money Flow: -1963460 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.91 - 2.81) Sell
Bollinger Bands (100): (2.2 - 2.82) Sell

PHAT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.16 Sell
Relative Strength Index (14 RSI): 29.68 Sell
Chaikin Money Flow: -1800545 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (8.14 - 9.2) Sell
Bollinger Bands (100): (10.05 - 17.69) Sell

GALT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.94 Sell
20-day SMA: 2.26 Sell
50-day SMA: 2.51 Sell
200-day SMA: 2.64 Sell
8-day EMA: 1.86 Sell
20-day EMA: 2.15 Sell
50-day EMA: 2.4 Sell
200-day EMA: 2.46 Sell

PHAT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 8.01 Sell
20-day SMA: 8.58 Sell
50-day SMA: 12.23 Sell
200-day SMA: 12.1 Sell
8-day EMA: 8.04 Sell
20-day EMA: 8.9 Sell
50-day EMA: 11.14 Sell
200-day EMA: 12.16 Sell

Galectin Therapeutics Earnings Growth & GALT Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Phathom Pharmaceuticals Earnings Growth & PHAT Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.64 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.94 per share, and an increase next year of $1.13 per share.

Galectin Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Phathom Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):